Nea Management Company, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Nea Management Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.7 - $1.07 $489,204 - $747,783	-698,863 Reduced 23.35%	2,294,095 $1.61 Million
Q4 2022 Feb 10, 2023	SELL	$0.61 - $5.06 $91,500 - $758,999	-150,000 Reduced 4.77%	2,992,958 $2.69 Million
Q2 2021 Aug 02, 2021	BUY	$4.8 - $7.25 $697,324 - $1.05 Million	145,276 Added 4.85%	3,142,958 $22.2 Million
Q1 2021 May 14, 2021	BUY	$4.57 - $7.18 $13.7 Million - $21.5 Million	2,997,682 New	2,997,682 $17.7 Million

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.